146
Caraballo
R, Valenzuela

GR. Cannabidiol-enriched

GR. Cannabidiol-enriched

medical

cannabis

as add-on

as add-on

therapy

in

children
with treatment-resistant
with treatment-resistant
West syndrome:

est syndrome: A study of eight patients. Seizure [Internet].

study of eight patients. Seizure [Internet].

study of eight patients. Seizure [Internet].

study of eight patients. Seizure [Internet].

study of eight patients. Seizure [Internet].

study of eight patients. Seizure [Internet].
2021
Nov 1 [cited 2022

Nov 1 [cited 2022

Nov 1 [cited 2022

Nov 1 [cited 2022 Aug 20];92:238–43.

Aug 20];92:238–43. Available from: https://linkinghub.

vailable from: https://linkinghub.

vailable from: https://linkinghub.
elsevier.com/retrieve/pii/S1059131121003216
Berger AA, Keefe J,
AA, Keefe J,

AA, Keefe J,

Winnick A, Gilbert E, Eskander JP

A, Gilbert E, Eskander JP

A, Gilbert E, Eskander JP

A, Gilbert E, Eskander JP

A, Gilbert E, Eskander JP,

Yazdi C, et al. Cannabis and cannabidiol

azdi C, et al. Cannabis and cannabidiol

azdi C, et al. Cannabis and cannabidiol

azdi C, et al. Cannabis and cannabidiol

azdi C, et al. Cannabis and cannabidiol

azdi C, et al. Cannabis and cannabidiol

azdi C, et al. Cannabis and cannabidiol
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin
(CBD) for the treatment of fbromyalgia. Best Pract Res Clin Anaesthesiol [Internet].
Anaesthesiol [Internet].
2020 Sep 1 [cited 2022 Aug 20];34(3):617–31. Available from: https://linkinghub.elsevier.
com/retrieve/pii/S1521689620300781
Sagy I, Bar
Sagy I, Bar
Sagy I, Bar-Lev Schleider L,
-Lev Schleider L,

-Lev Schleider L, Abu-Shakra M, Novack

Abu-Shakra M, Novack

Abu-Shakra M, Novack

V. Safety and Efficacy of Medical Cannabis

. Safety and Efcacy of Medical Cannabis

. Safety and Efcacy of Medical Cannabis

. Safety and Efcacy of Medical Cannabis

. Safety and Efcacy of Medical Cannabis

. Safety and Efcacy of Medical Cannabis

. Safety and Efcacy of Medical Cannabis
in Fibromyalgia. in Fibromyalgia. J Clin Med [Internet]. J Clin Med [Internet]. J Clin Med [Internet]. J Clin Med [Internet]. 2019 Jun 5 [cited 2019 Jun 5 [cited 2019 Jun 5 [cited 2019 Jun 5 [cited 2022 Aug 20];8(6):807. Aug 20];8(6):807. Available
from: https://www
from: https://www.mdpi.com/2077-0383/8/6/807
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Fitzcharles M-A, Rampakakis E, Sampalis JS, Shir
Y, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical

, Cohen M, Starr M, et al. Use of medical
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
cannabis by patients with fbromyalgia in Canada after cannabis legalisation: a cross-
sectional study
sectional study. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022
. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022

. Clin Exp Rheumatol [Internet]. 2021 Jun 21 [cited 2022 Aug
20];39(3):115–9. Available from: https://www
vailable from: https://www

vailable from: https://www.clinexprheumatol.org/abstract.
asp?a=17212
Gonen T, Amital
H. Cannabis and Cannabinoids in the

H. Cannabis and Cannabinoids in the

H. Cannabis and Cannabinoids in the

H. Cannabis and Cannabinoids in the

H. Cannabis and Cannabinoids in the

H. Cannabis and Cannabinoids in the Treatment

of Rheumatic

of Rheumatic

Diseases. Rambam

Diseases. Rambam
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022
Maimonides Med J [Internet]. 2020 Jan 30 [cited 2022 Aug 20];1
Aug 20];11(1):e0007. Available
from: https://www
from: https://www.rmmj.org.il/issues/44/articles/1025
Santarossa
TM, So R, Smyth DP

TM, So R, Smyth DP

TM, So R, Smyth DP

TM, So R, Smyth DP

TM, So R, Smyth DP, Gustavsen DS,

, Gustavsen DS,

, Gustavsen DS,

Tsuyuki DR

suyuki DRT. Medical cannabis use in

. Medical cannabis use in

. Medical cannabis use in

. Medical cannabis use in

. Medical cannabis use in
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
Canadians with multiple sclerosis. Mult Scler Relat Disord [Internet]. 2022 Mar
[cited 2022
[cited 2022 Aug 20];59:103638.
Aug 20];59:103638. Available

from: https:/

from: https://linkinghub.elsevier.com/retrieve/
pii/S2211034822001535
Fragoso
YD, Carra

YD, Carra A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother

A, Macias MA. Cannabis and multiple sclerosis. Expert Rev Neurother
[Internet]. 2020
[Internet]. 2020 Aug 2 [cited 2022
Aug 2 [cited 2022

Aug 2 [cited 2022

Aug 2 [cited 2022 Aug 20];20(8):849–54.

Aug 20];20(8):849–54. Available from: https://www

vailable from: https://www

vailable from: https://www.
tandfonline.com/doi/full/10.1080/14737175.2020.1776610
Lim K, See
Lim K, See
Lim K, See
YM, Lee J.

YM, Lee J.

YM, Lee J. A Systematic Review of the Effectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for

Systematic Review of the Efectiveness of Medical Cannabis for
Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol

Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol

Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol

Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol

Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol

Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol

Psychiatric, Movement and Neurodegenerative Disorders. Clin Psychopharmacol
Neurosci [Internet]. 2017 Nov 30 [cited 2022
Neurosci [Internet]. 2017 Nov 30 [cited 2022
Neurosci [Internet]. 2017 Nov 30 [cited 2022
Neurosci [Internet]. 2017 Nov 30 [cited 2022
Neurosci [Internet]. 2017 Nov 30 [cited 2022
Neurosci [Internet]. 2017 Nov 30 [cited 2022
Neurosci [Internet]. 2017 Nov 30 [cited 2022 Aug 20];15(4):301–12.
Aug 20];15(4):301–12. Available from: http://www

vailable from: http://www

vailable from: http://www.
cpn.or.kr/journal/view.html?doi=10.9758/cpn.2017.15.4.301
Paes-Colli
Y, Aguiar AFL, Isaac

AFL, Isaac AR, Ferreira BK, Campos RMP

AR, Ferreira BK, Campos RMP

AR, Ferreira BK, Campos RMP

AR, Ferreira BK, Campos RMP

AR, Ferreira BK, Campos RMP,

Trindade PMP

rindade PMP, et al.

, et al.

, et al.